Skip to main content

Table 4 Clinical features of 50 cases of ALK-DLBCL reported in the literature

From: ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

  N %/range
Age, years (n = 47) 38 9 – 72
Sex (n = 50)   
   Male 38 76
   Female 12 24
Site of involvement (n = 46)   
Exclusively nodal 24 52
   Cervical 17 71
   Other 7 29
Extranodal 22 48
   Bone 8 36
   Liver and spleen 4 18
   Head and neck 3 14
   Gastrointestinal tract 3 14
   Other* 8 36
Clinical stage (n = 47)   
   I – II 20 43
   III – IV 27 57
Therapy (n = 41)   
   Chemotherapy 34 83
   Chemoradiotherapy 6 15
   Radiotherapy 1 2
Relapsed cases 18 44
Salvage HSCT 8 20
Survival time, months (n = 36) 24 3 – 156
  1. HSCT – hematopoietic stem cell transplantation
  2. *Includes bone marrow, CNS, gonads and muscle